SUMMARY Forty six patients with endoscopically diagnosed duodenal ulceration were randomly allocated to treatment with either sucralfate 1 g qds (n=24) or cimetidine 200 mg tds and 400 mg nocte (n=22). When the ulcers healed, a maintenance dose of sucralfate 1 g bd or cimetidine 400 mg nocte was given for one year (or until relapse if earlier). Biopsies of duodenal mucosa adjacent to ulcer sites for light and electron microscopy were obtained before and after healing and again after one year's maintenance if the ulcer remained healed. Duodenal biopsies were also taken from 20 age and sex matched controls. Rates of healing and relapse during maintenance did not differ between the two treatments, although relapses occurred earlier with cimetidine. In the three year postmaintenance follow up period 10/13 cimetidine patients relapsed compared with four of 11 sucralfate patients (p<005), the relapses occurring significantly earlier in the cimetidine treated patients (p<OOS). Mucosal biopsies from both treatment groups still showed considerable abnormalities after healing. During maintenance, however, the sucralfate scores fell significantly (p<002) to near control levels unlike the cimetidine scores which remained raised at pretreatment values. The histological and ultrastructural changes were not predictive of later relapse. These findings favour the use of sucralfate in preference to cimetidine for maintenance treatment in the prevention of relapse of healed duodenal ulcers.
Comparison ofrelapse rates and of mucosal abnormalities after healing ofduodenal ulceration showed a correlation between the presence of gastric metaplasia and the length of remission, a greater degree of gastric metaplasia being present in the sucralfate patients with longer remission times.
The purpose of the present study was to compare the effect of long term maintenance treatment with sucralfate and cimetidine on the histological and ultrastructural changes in the duodenal mucosa adjacent to ulcer sites and to determine any possible relationship between these changes and the occurrence of relapse.
Methods

PATIENTS
A group of 46 patients between the ages of 18 and 75, with endoscopically proven duodenal ulceration were randomly allocated to treatment with either sucralfate 1 g qds (n=24) or cimetidine 200 mg tds and 400 mg nocte (n=22). Endoscopy was repeated at six weeks and if the ulcer was unhealed, the full dose was continued for a further six week period when a further endoscopy was done. If the ulcer remained unhealed the code was broken and alternative treatment given. If the ulcer was healed at six or 12 weeks, then maintenance treatment was continued for one year, or until relapse if earlier, with either sucralfate 1 g bd or cimetidine 400 mg hs. Endoscopy was repeated after one year or earlier if the patient had symptoms suggesting a relapse. If a relapse occurred alternative treatment or surgery was given. The patients remaining in remission at the end of one year's maintenance treatment have been followed up at three monthly intervals, the longest period so far being for 36 months. Sixteen patients in the sucralfate group and 18 patients in the cimetidine group were entered into the maintenance phase. There were no differences in the numbers or rates of relapse between the two treatment groups with four of 18 (22.2%) relapses in the cimetidine group and four of 16 (25%) relapses in the sucralfate group. Of the four relapses in the cimetidine group, two occurred at six months, one at nine months and one at 12 months whereas all four relapses in the sucralfate group (two symptomatic, two silent) were at 12 months.
At the end of the 12 month maintenance period, 13 patients in the cimetidine group and 11 of the sucralfate group were entered into the post-maintenance phase. The three year postmaintenance relapse rates are shown in Figure 3 . There was a significantly greater incidence of postmaintenance, endoscopically confirmed symptomatic relapse in the cimetidine group with 10/13 (76.9%) patients relapsing compared with four of 11 (36.4%) 
LIGHT AND ELECTRON MICROSCOPY
The overall total scores for light and electron microscopy, before, after healing and after one year's maintenance treatment for the two groups are detailed in Table 2 . There were no differences in the total scores between the cimetidine and sucralfate groups by either microscopic method over any of the treatment phases. In order to study the 'within' treatment changes in histology over the initial, healed and maintenance periods of the study, only those patients with satisfactory biopsies for both light and electron microscopy over each of the three periods were selected so that paired analyses could be done. This provided 10 cimetidine and nine sucralfate treated patients whose results are detailed in Table 3 . The scores on light microscopy were There were no differences in the electron microscopy scores between the three treatment phases in the cimetidine treated patients, although there was a trend for a fall in the score with healing. In the sucralfate group, whilst there were no differences between the initial and healed phases (although there was a reduction in the score), there was a significant improvement in the duodenal mucosa with a reduction in the score in the maintenance phase compared to the initial phase (p<002).
The individual light microscopy scores together with the total scores for light and electron microscopy in both treatment groups over the whole study are detailed in Table 4 . There were no differences in any of the individual light microscopy parameters either within or between the two treatment groups at any time throughout the study. Whilst some patients showed good correlation between light and electron microscopy scores, in others there was a wide variation such that overall there was no consistent relationship. The degree of gastric metaplasia was indicated by the combined light microscopy scores for villous loss, goblet cell loss and the presence of PAS staining mucus cells and corresponding electron Table 4 Median (range) individual and total light microscopy scores and total electron microscopy scores in the two treatment groups over the total period of the study 2((1-3)
Post maintenance, no relapse 1 ((-3)
(1(0-1)
Post maintenance, relapse
( Gastric metaplasia has been regarded as a response to hyperacidity and may be related to resistance to ulceration.2"22 Gregory,"" "2"26 (personal communication) whilst stating that a return to normal histology or ultrastructural morphology is the ideal accompaniment to ulcer healing, produced evidence that the presence of gastric metaplasia on healing represents a continuing defensive mechanism against hyperacidity and is associated with a higher remission rate than in those not showing this response. In our series, however, no correlation was found between gastric metaplasia and prolonged remission and our findings suggest that it is consistent with an unhealthy mucosa. This concept is supported by the finding that Campylobacter pylori infection in duodenal mucosa is found only in association with gastric metaplasia.27-It is also reported that prostaglandin E2 generation is reduced in duodenal mucosa in the presence of gastric metaplasia (Dr S Pugh, personal communication).
It is regrettable that the association of Campylobacter pylori with relapse of duodenal ulceration was unknown when this study was designed and consequently the staining and culture of biopsies were not included in the protocol. It is known, however, that neither cimetidine nor sucralfate have any effect on Campylobacter pylori infection. [31] [32] [33] A criticism of the present study is the poor correlation between the light and electron microscopy scorings in some patients. In this study the distance between the participating laboratories necessitated taking two individual biopsies close together. The degree of histological change, however, is known to vary from site to site in the duodenum, being greatest close to an ulcer site and least on the opposite wall.'22 This could account for the poor correlation in some specimens because of an unavoidable distance between biopsy sites. In addition, the extremely small size of the electron microscopy sections compared with those for light microscopy could result in the former being sampled from a more normal or abnormal part of the biopsy specimen.
In conclusion, the findings reported here favour the use of sucralfate in preference to cimetidine for maintenance treatment in the prevention of relapse of healed duodenal ulcers. Its safety is confirmed by the absence of any increase in serum aluminium concentrations or other haematological or biochemical changes. The differences in relapse rate and improved morphological appearance may be related to an increase in prostaglandin generation in response to sucralfate.336 microscopy study. 
